Recognized as a global leader in hyaluronic acid technology, and for always pioneering what's next, Fidia offers patients much more than pain relief solutions - we offer hope to live better.
The industry’s only 2-injection hyaluronic acid treatment for osteoarthritis (OA) knee pain
A new 3-injection hyaluronic acid treatment for osteoarthritis (OA) knee pain
The original safe, proven hyaluronic acid treatment for osteoarthritis (OA) knee pain
An acellular, shelf-stable, amniotic membrane-derived injectable allograft, which retains rich intrinsic beneficial properties of the amniotic membrane
A natural over-the-counter dietary supplement
A hyaluronic acid-based gel that provides temporary relief of vaginal dryness symptoms
Florham Park, N.J., December 2, 2019 – Fidia Farmaceutici S.p.A., a world leader in the research, development and manufacturing of hyaluronic acid-based products and its wholly owned subsidiary, Fidia Pharma USA Inc., introduce in the US, TRILURON™ (sodium hyaluronate).
CartiJoint™ FORTE is the First Product in Fidia’s New Dietary Supplement Portfolio; Uniquely formulated with bioactive Bio-Curcumin Curcugreen™